(1-甲基己基)铵硫酸盐 | 3595-14-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机硫酸及其衍生物
• 中文名称: (1-甲基己基)铵硫酸盐
• 英文名称: 1-methyl-hexylamine; sulfate
• 英文别名: 1-Methyl-hexylamin; Sulfat；bis[(1-methylhexyl)ammonium] sulphate；Tuaminoheptan；(1-Methylhexyl)ammonium sulphate；heptan-2-amine;sulfuric acid
• CAS: 3595-14-0
• 化学式: 2C₇H₁₇N*H₂O₄S
• 分子量: 328.517
• InChiKey: ASNSHZBVZYSNTB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.26
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  109
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• Theranostics platform and methods of use
  申请人：Sanford Burnham Prebys Medical Discovery Institute

  公开号：US10161929B2

  公开（公告）日：2018-12-25

  Theranostics platforms for identifying drugs and nutraceuticals for treatment of rare disease are described. The platforms comprise (a) a cell-phenotype image-enhancing instrument; (b) a drug/nutraceutical library; and (c) a computer-implemented system for analyzing a response of an optically-visible rare-disease cell phenotype to a drug or nutraceutical from the drug/nutraceutical library.

  本文描述了用于识别治疗罕见病的药物和营养保健品的血清学平台。这些平台包括：(a) 细胞表型图像增强仪器；(b) 药物/营养保健品库；(c) 计算机实施系统，用于分析光学可视罕见疾病细胞表型对药物/营养保健品库中药物或营养保健品的反应。
• Method of Treating Transplant Rejection and Autoimmune Diseases
  申请人：Wisconsin Alumni Research Foundation

  公开号：US20140050694A1

  公开（公告）日：2014-02-20

  A method of treating autoimmune diseases and transplant rejection, comprising the step of treating the autoimmune or transplant patient with an effective amount of SU-5416 is disclosed.
• Insulin-Mimetic Composite for Bone Repair
  申请人：New Jersey Institute of Technology

  公开号：US20170252487A1

  公开（公告）日：2017-09-07

  The present disclosure generally relates to a composite scaffold containing insulin-mimetic materials for healing bone defects (e.g., bone repair). In particular, the present disclosure relates to a fibrous composite containing a synthetic polymer, nanoceramic and a vanadium salt to improve the healing of bone defects.
• THERAPY FOR NEUROLOGICAL DISEASES/DISORDERS
  申请人：Akassoglou Katerina

  公开号：US20210330611A1

  公开（公告）日：2021-10-28

  Provided herein are compositions and methods to treat or prevent neurodegeneration in a mammal, inhibit microglial activation in the CNS of a mammal, promote survival of CNS neurons in a mammal, prevent or reduce the rate of demyelination and/or neuronal injury in a mammal, promote remyelination in a mammal and/or treat or prevent or decrease oxidative stress in a mammal.